Schedule 13G ownership disclosure

Clementia Pharmaceuticals Inc.

Security class unavailable · CUSIP: 185575107

Event date: 2017-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,497,607
Percent of class
17.3300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000930413-18-000384
Form type
SC 13G
Filer
BDC CAPITAL INC.
CIK
CIK 1430885
Filed
Feb 14, 2018
Reporting period
Dec 31, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub